Maximilian Stahl, MD, is the Director of the Leukemia Program and an Assistant Professor of Medicine (Medical Oncology and Hematology). He cares for patients with hematologic malignancies at Smilow Cancer Hospital in New Haven with a particular focus on acute and chronic leukemias and myelodysplastic syndromes. Dr. Stahl joins Yale from Dana Farber Cancer Institute and Harvard Medical School where he was an Assistant Professor of Medicine within their Adult Leukemia Program.
Dr. Stahl received his medical degree from Hannover Medical School in Hannover, Germany and completed residency training at Yale School of Medicine where he also served as chief medical resident. He then completed a fellowship in Hematology and Medical Oncology at Memorial Sloan Kettering Cancer Center. His clinical research evaluates outcomes achieved with novel therapeutic approaches for AML, MDS, and MPNs, with a focus on identifying molecular predictors of these outcomes.
Dr. Stahl actively leads translational research with the goal of bringing basic scientific discoveries from the lab to the clinic to benefit patients with leukemia. Towards this goal, he conducts early phase clinical trials testing novel treatment approaches.
Location and Contact:
Hematology Program
Smilow Cancer Hospital at New Haven
35 Park Street
New Haven, CT 06511
Appointments: 203-200-4363